<DOC>
	<DOCNO>NCT01390883</DOCNO>
	<brief_summary>The purpose study collect ass information safety efficacy fondaparinux patient undergo abdominal surgery urology , obstetrics gynecology department high risk venous thromboembolism .</brief_summary>
	<brief_title>Special Drug Use Investigation ARIXTRA ( Fondaparinux ) Abdominal ( Urology , Obstetrics , Gynecology )</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Patients undergo abdominal surgery urology , obstetrics gynecology department Patients history hypersensitivity ingredient fondaparinux Patients bleed ( bleed important organ , sucn retroperitoneal bleed ) Patients acute bacterial endocarditis Patients severe renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>